Clinical trial
CAP-AF: Continued Access Protocol for the Evaluation of Catheter Cryoablation in the Treatment of Paroxysmal Atrial Fibrillation
NCT00889681 is registered in ClinicalTrials.gov with Medtronic Cardiac Rhythm and Heart Failure as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CAP-AF: Continued Access Protocol for the Evaluation of Catheter Cryoablation in the Treatment of Paroxysmal Atrial Fibrillation
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart Failure
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 31, 2009
- Completion date
- October 31, 2013
- Enrollment
- 81 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.